Delivery Order SPE2D018D0005-SPE2D326F3361
Award Date 1/7/26
Potential Completion Date 1/8/26
Potential Value $1K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Raritan, NJ 08869, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Health Agency (operating under the Medical Supply Chain) awarded a fixed-price delivery order valued at $2,716.20 to Ortho-Clinical Diagnostics, Inc. for Anti-A Bioclone 150ML monoclonal antibody reagent with ABO blood group typing capabilities. This delivery order, issued December 5, 2025, with an ultimate completion date of March 2, 2026, represents a task order issued under the company's existing Indefinite Delivery Contract vehicle. The contract utilized open competition...
- Ortho-Clinical Diagnostics, Inc. was awarded a delivery order valued at $3,927.36 by the Defense Health Agency's Medical Supply Chain on January 6, 2026, for the supply of Anti-A B Bioclone 10mL bottles for orthopedic blood bank applications. The contract is structured as a firm fixed-price delivery order with no set-aside designation, with performance to be completed by January 7, 2026, at the contractor's facility in Raritan, New Jersey. This award represents a task order placement under the...
- Ortho-Clinical Diagnostics, Inc. was awarded a delivery order valued at $2,074.46 by the Defense Health Agency's Medical Supply Chain on August 5, 2025, for the supply of Rh antigen anti-D blood bank reagent in 150ml monoclonal ABO group format. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Performance is scheduled for completion by August 8, 2025, at the contractor's facility in Raritan, New Jersey. This delivery order represents a...
- The Defense Medical Supply Chain awarded a delivery order to Ortho-Clinical Diagnostics, Inc. for Anti-A Bioclone 15x10mL, a blood bank reagent product, with a fixed-price ceiling value of $1,156.61. The award was issued on November 7, 2025, with an ultimate completion date of November 13, 2025. This delivery order was issued under the Critical Analyzers, Laboratory (FSS-66-III) General Services Administration Schedule, a governmentwide acquisition vehicle that streamlines procurement of...
- Ortho-Clinical Diagnostics, Inc. was awarded a $1,953.50 delivery order by the Defense Health Agency's Medical Supply Chain on November 24, 2025, for Reagent Anti-D Bioclone 150ML in the ABO Group BB blood typing classification. The contract utilizes a firm fixed price structure with no set-aside designation and is scheduled for completion by November 25, 2025. Performance will occur at the contractor's Raritan, New Jersey facility, where Ortho-Clinical Diagnostics manufactures advanced...
- The Defense Health Agency awarded Ortho-Clinical Diagnostics, Inc. a firm fixed-price purchase order valued at $107,550.60 for ortho blood bank reagents on April 17, 2023. The contract, which has no set-aside designation and reflects open competition, will be performed at Fort Irwin, California, with an ultimate completion date of April 16, 2028. Ortho-Clinical Diagnostics is a medical equipment manufacturer headquartered in Raritan, New Jersey, specializing in advanced diagnostic solutions...
- The U.S. Defense Department's Medical Supply Chain agency awarded a delivery order valued at $1,109.97 to Ortho-Clinical Diagnostics, Inc. for Anti-B Bioclone 15x10ML on August 11, 2025, with completion targeted for August 14, 2025. The contract utilizes fixed-price pricing with economic price adjustment and carries no set-aside designation, indicating open competition. Ortho-Clinical Diagnostics, headquartered in Raritan, New Jersey, is a for-profit medical equipment manufacturer specializing...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $1,109.97 to Ortho-Clinical Diagnostics, Inc. for Anti-A Bioclone 15x10ML on August 1, 2025, with an ultimate completion date of August 6, 2025. The contract utilizes fixed-price pricing with economic price adjustment and carries no set-aside designation, indicating open competition. Performance will occur at the contractor's facility in Raritan, New Jersey. Ortho-Clinical Diagnostics, Inc., a for-profit...
- Ortho-Clinical Diagnostics, Inc. was awarded a $106,667.83 delivery order for automated blood grouping equipment and services by the Defense Health Agency on September 28, 2021, with a completion date of September 27, 2023. This firm fixed-price contract, which utilized no set-aside designation, represents a task order under the General Services Administration's Critical Analyzers, Laboratory (FSS-66-III) schedule. The work is to be performed at the contractor's facility in Raritan, New...
- The Defense Department's Medical Supply Chain has awarded a delivery order valued at $4.7K to Ortho-Clinical Diagnostics, Inc. for blood group serum, effective June 2, 2025, with an ultimate completion date of June 23, 2025. This fixed-price delivery order with economic price adjustment provisions will be performed at the contractor's facility in Raritan, New Jersey. The contract was awarded without set-aside designations, indicating open competition among qualified vendors. Ortho-Clinical...